{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:50:40Z","timestamp":1790790640420,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.critrevonc.2022.103643","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T18:01:56Z","timestamp":1645552916000},"page":"103643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Low-risk triple-negative breast cancers: Clinico-pathological and molecular features"],"prefix":"10.1016","volume":"172","author":[{"given":"Nicola","family":"Fusco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Venetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Andaloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Guerini-Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Caldarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103643_bib1","article-title":"Adenoid cystic carcinoma of the breast and intraoperative electron radiotherapy: single case report and review of literature","author":"Accardo","year":"2021","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103643_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1309\/CRWUA3K0MPQHQC4W","article-title":"Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast","volume":"123","author":"Albores-Saavedra","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2005.07.010","article-title":"The sclerosing variant of adenoid cystic carcinoma: a previously unrecognized neoplasm of major salivary glands","volume":"10","author":"Albores-Saavedra","year":"2006","journal-title":"Ann. Diagn. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103643_bib5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103643_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1634\/theoncologist.2010-0036","article-title":"Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status","volume":"15","author":"Amar","year":"2010","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103643_bib7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1634\/theoncologist.2010-0036","article-title":"Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status","volume":"15","author":"Amar","year":"2010","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jso.26129","article-title":"Triple-negative apocrine carcinoma: a rare pathologic subtype with a better prognosis than other triple-negative breast cancers","volume":"122","author":"Arciero","year":"2020","journal-title":"J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103643_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdz292","article-title":"St Gallen International Consensus Guidelines in early breast cancer: experts to prevent patients\u2019 overtreatment and breaking the bank?","volume":"30","author":"Arnedos","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00428-005-0084-2","article-title":"Polymorphous adenocarcinoma of the breast. Report of three cases","volume":"448","author":"Asioli","year":"2006","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/tbj.13288","article-title":"Outcomes in patients with small node-negative invasive breast cancer","volume":"25","author":"Bao","year":"2019","journal-title":"Breast J."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000331316","article-title":"Mucoepidermoid carcinoma in a breast affected by burn scars: comprehensive literature review and case report","volume":"6","author":"Basbug","year":"2011","journal-title":"Breast Care"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/his.13514","article-title":"High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast","volume":"73","author":"Bataillon","year":"2018","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/his.13962","article-title":"Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast","volume":"75","author":"Beca","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00428-019-02640-7","article-title":"Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland","volume":"476","author":"Bell","year":"2020","journal-title":"Virchows Arch."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103643_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1066896916642011","article-title":"Solid variant of adenoid cystic carcinoma: difficulties in diagnostic recognition","volume":"24","author":"Ben Salha","year":"2016","journal-title":"Int. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103643_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/his.12358","article-title":"Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin","volume":"65","author":"Boecker","year":"2014","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.breast.2011.11.006","article-title":"Clinical review--breast adenoid cystic carcinoma","volume":"21","author":"Boujelbene","year":"2012","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.20892\/j.issn.2095-3941.2019.0465","article-title":"Triple negative breast cancer: special histological types and emerging therapeutic methods","volume":"17","author":"Cao","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2022.103643_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1101\/mcs.a002626","article-title":"Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making","volume":"4","author":"Chahal","year":"2018","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"51","key":"10.1016\/j.critrevonc.2022.103643_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009385","article-title":"Mucoepidermoid carcinoma of the breast: Four case reports and review of the literature","volume":"96","author":"Cheng","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2022.103643_bib23","article-title":"Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses","author":"Cima","year":"2021","journal-title":"Virchows Arch."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103643_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41379-020-00697-3","article-title":"Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls","volume":"34","author":"Cimino-Mathews","year":"2021","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103643_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.humpath.2015.12.014","article-title":"Acinic cell carcinoma of breast: morphologic and immunohistochemical review of a rare breast cancer subtype","volume":"51","author":"Conlon","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib27","article-title":"Immunotherapy in breast cancer patients: a focus on the use of the currently available biomarkers in oncology","author":"Criscitiello","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"issue":"22","key":"10.1016\/j.critrevonc.2022.103643_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225694","article-title":"Triple-negative breast cancer histological subtypes with a favourable prognosis","volume":"13","author":"Cserni","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jclinpath-2018-205485","article-title":"Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast","volume":"72","author":"D'Arcy","year":"2019","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.ro.2018.08.005","article-title":"Low-grade adenosquamous carcinoma of the breast: a case report","volume":"53","author":"Delgado Hardegree","year":"2018","journal-title":"Semin. Roentgenol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clbc.2012.11.004","article-title":"Immunohistochemically defined subtypes and outcome of apocrine breast cancer","volume":"13","author":"Dellapasqua","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103643_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1634\/theoncologist.2014-0108","article-title":"Rare breast cancer subtypes: histological, molecular, and clinical peculiarities","volume":"19","author":"Dieci","year":"2014","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/PAS.0000000000000853","article-title":"Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms: a unique invasive tumor with indolent behavior","volume":"41","author":"Foschini","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pathol.2016.10.011","article-title":"The morphological spectrum of salivary gland type tumours of the breast","volume":"49","author":"Foschini","year":"2017","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1066896914548795","article-title":"The birth of an adenoid cystic carcinoma","volume":"23","author":"Fusco","year":"2015","journal-title":"Int. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/his.12735","article-title":"Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing","volume":"68","author":"Fusco","year":"2016","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103643_bib37","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/modpathol.2016.134","article-title":"Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer","volume":"29","author":"Fusco","year":"2016","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib38","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/his.13165","article-title":"Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-alpha expression in pulmonary adenofibromas","volume":"70","author":"Fusco","year":"2017","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/genes11070719","article-title":"PTEN alterations and their role in cancer management: are we making headway on precision medicine?","volume":"11","author":"Fusco","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2022.103643_bib40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fonc.2021.644737","article-title":"PIK3CA mutations as a molecular target for hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"11","author":"Fusco","year":"2021","journal-title":"Front. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103643_bib41","first-page":"31","article-title":"Tumor-infiltrating lymphocytes in triple negative breast cancer: the future of immune targeting","volume":"10","author":"Garc\u00eda-Teijido","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103643_bib42","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ajpath.2017.03.016","article-title":"The spectrum of triple-negative breast disease: high- and low-grade lesions","volume":"187","author":"Geyer","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/modpathol.2016.161","article-title":"Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family","volume":"30","author":"Geyer","year":"2017","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib44","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/bcr2613","article-title":"Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study","volume":"12","author":"Ghabach","year":"2010","journal-title":"Breast Cancer Res. BCR"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103643_bib45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.MP.0000085027.75201.B5","article-title":"Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas","volume":"16","author":"Gobbi","year":"2003","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00000478-200106000-00017","article-title":"Solitary cylindroma (dermal analog tumor) of the breast: a previously undescribed neoplasm at this site","volume":"25","author":"Gokaslan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103643_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3892\/ol.2020.12000","article-title":"Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization","volume":"20","author":"Gomez-Macias","year":"2020","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103643_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/path.5406","article-title":"The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice","volume":"250","author":"Gonzalez-Ericsson","year":"2020","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/path.4566","article-title":"The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study","volume":"237","author":"Guerini-Rocco","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib50","article-title":"Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement","author":"Guerini-Rocco","year":"2021","journal-title":"Tumori"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib51","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1007\/s11033-020-05553-w","article-title":"Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report","volume":"47","author":"Haefliger","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2022.103643_bib52","article-title":"Cutaneous adnexal cylindroma of breast: epithelial immunoreactivities for GATA-3, mammaglobin, and E-cadherin do not equate to a mammary ductal neoplasm","volume":"2018","author":"Halima","year":"2018","journal-title":"Case Rep. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ng.2643","article-title":"The mutational landscape of adenoid cystic carcinoma","volume":"45","author":"Ho","year":"2013","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/his.13879","article-title":"Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential","volume":"75","author":"Hoda","year":"2019","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103643_bib55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1827.2006.02004.x","article-title":"Muco-epidermoid carcinoma of the breast","volume":"56","author":"Horii","year":"2006","journal-title":"Pathol. Int."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103643_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.breast.2012.02.013","article-title":"Secretory carcinoma of the breast: results from the survival, epidemiology and end results database","volume":"21","author":"Horowitz","year":"2012","journal-title":"Breast"},{"issue":"15","key":"10.1016\/j.critrevonc.2022.103643_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153739","article-title":"Precision medicine and triple-negative breast cancer: current landscape and future directions","volume":"13","author":"Hossain","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2019.100501","article-title":"The role of histopathologic testing on apocrine carcinoma of the breast","volume":"44","author":"Ilhan","year":"2020","journal-title":"Curr. Probl. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib59","first-page":"183","article-title":"Tall cell carcinoma with reverse polarity of breast: report of a case with unique morphologic and molecular features","volume":"37","author":"Jassim","year":"2021","journal-title":"Turk. Patoloji Derg."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib60","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr3633","article-title":"Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling","volume":"16","author":"Jindal","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103643_bib61","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1159\/000508181","article-title":"A case of squamous cell carcinoma of the breast with low-grade adenosquamous carcinoma","author":"Kashu","year":"2020","journal-title":"Case Rep. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.5006","article-title":"MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene","volume":"244","author":"Kim","year":"2018","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib63","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/15384047.2019.1595274","article-title":"Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature review","volume":"20","author":"Kryklyva","year":"2019","journal-title":"Cancer Biol Ther."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib64","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1245\/s10434-013-2911-z","article-title":"Rare breast cancer: 933 adenoid cystic carcinomas from the national cancer data base","volume":"20","author":"Kulkarni","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103643_bib66","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/bcr3421","article-title":"Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15","volume":"15","author":"Lehmann-Che","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103643_bib67","first-page":"47","article-title":"Pure acinic cell carcinoma of the breast: a case report and literature review","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2018.0035","article-title":"Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma","volume":"16","author":"Li","year":"2019","journal-title":"Cancer Biol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103643_bib69","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.ijsu.2014.05.004","article-title":"Acinic cell carcinoma of the breast: review of the literature","volume":"12","author":"Limite","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.critrevonc.2022.103643_bib70","doi-asserted-by":"crossref","first-page":"v608","DOI":"10.1093\/annonc\/mdx440.005","article-title":"Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): results from KEYNOTE-086","volume":"28","author":"Loi","year":"2017","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib71","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1200\/JCO.18.01010","article-title":"Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers","volume":"37","author":"Loi","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms21041461","article-title":"PTEN expression as a complementary biomarker for mismatch repair testing in breast cancer","volume":"21","author":"Lopez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2022.103643_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1746-1596-4-30","article-title":"Cylindroma of the breast: a case report and review of the literature","volume":"4","author":"Mahmoud","year":"2009","journal-title":"Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152500","article-title":"The prognostic value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis","volume":"11","author":"Mao","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103643_bib75","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jcp.2009.073908","article-title":"Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas)","volume":"63","author":"Marchio","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41523-020-00197-2","article-title":"Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies","volume":"6","author":"Marra","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.critrevonc.2022.103643_bib77","doi-asserted-by":"crossref","unstructured":"Massoumi R., Paus R. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. BioEssays: news and reviews in molecular, cellular and developmental biology. 2007; 29(12):1203\u20131214.","DOI":"10.1002\/bies.20677"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103643_bib78","article-title":"Tall cell carcinoma with reversed polarity of the breast","volume":"13","author":"Matute","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2022.103643_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijerph17062078","article-title":"Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies","volume":"17","author":"Medina","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103643_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153140","article-title":"Clear cell papillary neoplasm of the breast with MAML2 gene rearrangement: clear cell hidradenoma or low-grade mucoepidermoid carcinoma?","volume":"216","author":"Memon","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.critrevonc.2022.103643_bib81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.breast.2020.07.003","article-title":"Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy","volume":"53","author":"Montagna","year":"2020","journal-title":"Breast"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103643_bib82","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/tbj.14069","article-title":"Incidence, clinical features, and outcomes of special types in breast cancer in a single institution population","volume":"26","author":"Moorman","year":"2020","journal-title":"Breast J."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103643_bib83","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/onco.13880","article-title":"Locally recurrent secretory carcinoma of the breast with NTRK3 gene fusion","volume":"26","author":"Mortensen","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2022.103643_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/187623","article-title":"Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer","volume":"2011","author":"Murase","year":"2011","journal-title":"Int. J. Otolaryngol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-016-1963-4","article-title":"The unique luminal staining pattern of cytokeratin 5\/6 in adenoid cystic carcinoma of the breast may aid in differentiating it from its mimickers","volume":"469","author":"Nakai","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2022.103643_bib86","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humpath.2021.07.005","article-title":"\u03b1-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation","volume":"116","author":"Nakamura","year":"2021","journal-title":"Human Pathol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103643_bib87","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/01.pas.0000126774.27698.27","article-title":"Cylindroma of the breast of skin adnexal type: a study of 4 cases","volume":"28","author":"Nonaka","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib88","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s42399-021-00769-8","article-title":"Fibromatosis-like metaplastic breast carcinoma mimicking IgG4-related Sclerosing mastitis: a case report","volume":"3","author":"Ogliari","year":"2021","journal-title":"SN Compr. Clin. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103643_bib89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5114\/pjp.2013.38141","article-title":"Primary mucoepidermoid carcinoma of the breast: a case report with immunohistochemical analysis and comparison with salivary gland mucoepidermoid carcinomas","volume":"64","author":"Palermo","year":"2013","journal-title":"Pol. J. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib90","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41523-020-0164-0","article-title":"Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes","volume":"6","author":"Pareja","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib91","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41379-019-0442-2","article-title":"Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity","volume":"33","author":"Pareja","year":"2020","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103643_bib92","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/annonc\/mdz395","article-title":"Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy","volume":"30","author":"Park","year":"2019","journal-title":"Ann. Oncol."},{"issue":"44","key":"10.1016\/j.critrevonc.2022.103643_bib93","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc. Ntl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib94","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jcp.56.7.497","article-title":"Salivary gland-like tumours of the breast: surgical and molecular pathology","volume":"56","author":"Pia-Foschini","year":"2003","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib95","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/his.12673","article-title":"Are acinic cell carcinomas of the breast and salivary glands distinct diseases?","volume":"67","author":"Piscuoglio","year":"2015","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103643_bib96","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/his.12712","article-title":"MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast","volume":"67","author":"Piscuoglio","year":"2015","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib97","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/his.12883","article-title":"Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland","volume":"68","author":"Piscuoglio","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103643_bib98","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijscr.2019.02.029","article-title":"Secretory carcinoma of the breast: a case report","volume":"56","author":"Pohlodek","year":"2019","journal-title":"Int. J. Surg. Case Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/his.12861","article-title":"Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management","volume":"68","author":"Rakha","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103643_bib100","article-title":"Spindle cell lesions of the breast: a diagnostic approach","author":"Rakha","year":"2021","journal-title":"Virchows Archiv."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib101","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/PAI.0b013e31826a277e","article-title":"Salivary gland-like tumors of the breast express basal-type immunohistochemical markers","volume":"21","author":"Reyes","year":"2013","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-014-1603-9","article-title":"Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype","volume":"465","author":"Rito","year":"2014","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib103","article-title":"Low-grade adenosquamous carcinoma of the breast: a review with focus on imaging and management","volume":"10","author":"Romanucci","year":"2021","journal-title":"Acta Radiol. Open"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00196823","article-title":"Acinic cell-like carcinoma of the breast","volume":"429","author":"Roncaroli","year":"1996","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2022.103643_bib105","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3332\/ecancer.2020.1150","article-title":"Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?","volume":"14","author":"Sajjadi","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib106","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1186\/s12885-021-08889-z","article-title":"Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling","volume":"21","author":"Sajjadi","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103643_bib107","first-page":"43","article-title":"Primary acinic cell carcinoma of the breast is associated with a poor outcome: A case report and literature review","author":"Sarsiat","year":"2022","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib108","article-title":"Breast carcinomas of low malignant potential","author":"Schnitt","year":"2021","journal-title":"Virchows Arch."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib109","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/PAI.0000000000000604","article-title":"Columnar cell lesion and apocrine hyperplasia of the breast: is there a common origin? The role of prolactin-induced protein","volume":"27","author":"Sciarra","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/his.13854","article-title":"Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma","volume":"75","author":"Sebastiao","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103643_bib111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.amsu.2018.09.030","article-title":"Primary acinic cell carcinoma of the breast: a case report with a clinicopathological and immunohistochemical study of a rare breast cancer subtype","volume":"35","author":"Sen","year":"2018","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.critrevonc.2022.103643_bib112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijscr.2015.06.040","article-title":"Bilateral synchronous low-grade adenosquamous carcinoma of the breast: a Case report with review of the current literature","volume":"14","author":"Senger","year":"2015","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.critrevonc.2022.103643_bib113","doi-asserted-by":"crossref","DOI":"10.4103\/IJPM.IJPM_367_18","article-title":"Secretory carcinoma of breast: a diagnostic dilemma","volume":"63","author":"Shukla","year":"2020","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"15_suppl","key":"10.1016\/j.critrevonc.2022.103643_bib114","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2019.37.15_suppl.536","article-title":"Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC)","volume":"37","author":"Steenbruggen","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejca.2020.04.033","article-title":"Adjuvant chemotherapy in small node-negative triple-negative breast cancer","volume":"135","author":"Steenbruggen","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib116","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40792-021-01110-0","article-title":"A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report","volume":"7","author":"Takatsuka","year":"2021","journal-title":"Surg. Case Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103643_bib118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijsu.2015.05.010","article-title":"Low-grade adenosquamous carcinoma of the breast: a diagnostic and clinical challenge","volume":"19","author":"Tan","year":"2015","journal-title":"Int.l J. Surg."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103643_bib119","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/tbj.13840","article-title":"Low-grade adenosquamous carcinoma of the breast","volume":"26","author":"Thornley","year":"2020","journal-title":"Breast J."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib120","doi-asserted-by":"crossref","first-page":"644","DOI":"10.5858\/arpa.2015-0250-RA","article-title":"Pathologic spectrum of secretory and mucinous breast lesions","volume":"140","author":"Toll","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12282-017-0780-1","article-title":"Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature","volume":"25","author":"Treitl","year":"2018","journal-title":"Breast Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103643_bib122","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/tbj.13623","article-title":"Polymorphous adenocarcinoma of the breast-an exceptionally rare entity: clinicopathological description of a case and brief review","volume":"26","author":"Trihia","year":"2020","journal-title":"Breast J."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103643_bib123","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/tbj.14165","article-title":"Tall cell carcinoma with reversed polarity: a case report of a very rare breast tumor entity and mini-review","volume":"27","author":"Trihia","year":"2021","journal-title":"Breast J."},{"key":"10.1016\/j.critrevonc.2022.103643_bib124","article-title":"Grading of invasive breast carcinoma: the way forward","author":"van Dooijeweert","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2022.103643_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/S0960-9776(21)00081-3","article-title":"Pathology after neoadjuvant treatment - how to assess residual disease","author":"Viale","year":"2021","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13000-020-00943-x","article-title":"Fibromatosis-like metaplastic carcinoma: a case report and review of the literature","volume":"15","author":"Victoor","year":"2020","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib127","article-title":"An update on the molecular and clinical characteristics of apocrine carcinoma of the breast","author":"Vranic","year":"2021","journal-title":"Clin. Breast Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103643_bib128","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/modpathol.2010.50","article-title":"EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast","volume":"23","author":"Vranic","year":"2010","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103643_bib129","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.humpath.2015.05.017","article-title":"Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast","volume":"46","author":"Vranic","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib130","doi-asserted-by":"crossref","DOI":"10.1177\/10668969211008508","article-title":"Acinic cell carcinoma of the breast: report of a case with immunohistochemical and next-generation sequencing studies","author":"Weaver","year":"2021","journal-title":"Int. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103643_bib131","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ng.3096","article-title":"Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands","volume":"46","author":"Weinreb","year":"2014","journal-title":"Nat. Genet."},{"issue":"15_suppl","key":"10.1016\/j.critrevonc.2022.103643_bib132","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.e13071","article-title":"Novel treatment options in advanced adenoid cystic carcinoma of the breast","volume":"39","author":"Wenig","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib133","unstructured":"WHO Classification of Tumours Editorial Board, WHO Classification of Breast Tumours: WHO Classification of Tumours, Volume 2: World Health Organization; 2019."},{"issue":"20","key":"10.1016\/j.critrevonc.2022.103643_bib134","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of american pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib135","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple\u2011negative breast cancer therapy: current and future perspectives (Review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103643_bib136","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/gcc.22929","article-title":"Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components","volume":"60","author":"Xu","year":"2021","journal-title":"Genes Chromosom. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103643_bib137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1066896920916779","article-title":"Mucoepidermoid carcinoma of the breast With MAML2 rearrangement: a case report and literature review","volume":"28","author":"Yan","year":"2020","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib138","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3389\/fonc.2020.01714","article-title":"Low-grade adenosquamous carcinoma of the axilla of breast origin in a male: a case report and literature review","volume":"10","author":"Yan","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib139","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13000-020-00992-2","article-title":"A novel collision tumour of myofibroblastoma and low-grade adenosquamous carcinoma in breast","volume":"15","author":"Yang","year":"2020","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103643_bib140","doi-asserted-by":"crossref","first-page":"95-","DOI":"10.1186\/s13000-019-0872-7","article-title":"Pure secretory carcinoma in situ: a case report and literature review","volume":"14","author":"Yang","year":"2019","journal-title":"Diagn. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103643_bib141","first-page":"3192","article-title":"Breast mucoepidermoid carcinoma: a case report and review of literature","volume":"13","author":"Ye","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103643_bib142","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/annonc\/mdp245","article-title":"Breast carcinoma--rare types: review of the literature","volume":"20","author":"Yerushalmi","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib143","first-page":"11","article-title":"Management of adenoid cystic carcinoma of the breast: a single-institution study","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103643_bib144","doi-asserted-by":"crossref","unstructured":"Zhang X., Wu H., Wang Z., Zhou Y., Mao F., Lin Y., et al. Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review. Gland Surg. 10: 2021 Gland Surgery. All rights reserved; 2021. p. 837\u2013843.","DOI":"10.21037\/gs-20-695"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:42:14Z","timestamp":1760902934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":144,"alternative-id":["S1040842822000671"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103643","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-risk triple-negative breast cancers: Clinico-pathological and molecular features","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103643"}}